贝施美与意大利历德医疗达成战略合作 共启中国口腔种植领域全新篇章

2026年1月23日，成都贝施美医疗科技股份有限公司（以下简称“贝施美”）与全球顶尖的口腔种植企业历德医疗（Leader Medica，以下简称“LM”）在成都正式签署战略合作协议。此次合作不仅是双方企业战略布局的重要一步，更是中国口腔医疗产业与国际领先技术对接的里程碑事件，标志着中国口腔种植领域迈向更高水平、更广视野的全新阶段。根据协议，贝施美将成为历德医疗中国区总代理，双方将整合核心资源、发挥优势互补，共同为中国口腔医疗市场带来国际前沿的种植技术与产品解决方案，重塑中国消费者口腔种植体验，推动行业向标准化、国际化、高端化迈进。

此次战略合作的达成，历经半年多的深度考察与磋商，体现了双方对合作的高度重视与长远规划。期间，历德医疗团队多次到访位于成都天府国际生物城的贝施美数字智造基地，全方位考察其企业规模、研发实力、智能制造能力，市场运营能力及全球供应链布局。贝施美现代化的生产基地、覆盖全产业链的研发体系、完善的全球服务网络，以及作为美国BioRes授权生产制造合作伙伴的核心资质，最终赢得了历德医疗的高度认可与信赖，为双方携手奠定了坚实基础。

签约仪式于当日下午16时隆重举行，历德医疗代表Andrea Minozzi、Congzhong Han与贝施美创始人鄢新章先生共同签署协议，见证这一跨越国界的行业合作里程碑。作为各自领域的领军者，双方的携手被业内视为“全球技术与中国智造”的完美融合，将为口腔医疗行业注入强劲发展动能。

创立于1994年的历德医疗，深耕口腔种植领域近三十年，始终专注于该领域的设备研发、生产与创新，目前已建立起覆盖口腔种植全产业链的12条产品线，从原料加工、精密车削到最终包装实现全流程自主生产，并以卓越的产品品质和融合数字化的持续创新享誉全球。历德医疗代表Andrea Minozzi在签约仪式上表示：“历德医疗自成立以来，始终将产品品质和与学术界、科研界的深度共生置于发展的核心。我们每一代产品的迭代升级，都离不开与全球高校、科研专家的紧密协作，这已成为我们的品牌基因。此次选择与贝施美达成长期战略合作，正是基于双方在坚守品质、联动科研创新以及数字化前瞻布局上的高度共识。未来，历德医疗的种植体产品将依托贝施美全面进入中国市场，而贝施美的先进技术也将通过历德医疗落地欧洲，真正实现双向赋能、长远共赢。”

贝施美创始人鄢新章先生指出：“种植牙技术发源于欧洲，历经长期积淀与演进，形成了深厚的学术与产业基础。我们选择历德医疗，正是看重其悠久的发展历史、扎实的研发底蕴与严苛的产品体系。贝施美始终致力于推动口腔种植领域的技术创新与产业进步，引入历德医疗这款优秀的意大利种植体，正是这一使命的延伸。我们由衷期待，通过双方的合作，能让历德医疗的优质产品惠及中国更广阔的市场，让国内患者享受到与国际同步的先进种植解决方案。”

作为中国数字化口腔领域的标杆企业，贝施美自2013年成立以来，始终以自主创新为核心，构建了涵盖全瓷材料、种植体及数字化口腔设备的全产业链布局，凭借“技术智造+赋能系统”双重优势，为全球客户提供一站式口腔解决方案。目前，贝施美已斩获国家NMPA、欧盟CE、美国FDA等多项权威认证，拥有100余项国内外专利授权，业务版图覆盖全球100多个国家和地区，展现了中国智造在全球医疗健康领域中的崛起实力与责任担当。

此次合作，是贝施美在全球合作布局中的又一重要突破，也是企业践行国际化战略、整合全球先进资源的关键一步。继与美国BioRes达成深度合作后，贝施美再度携手历德医疗，将进一步丰富其产品矩阵，强化在口腔种植领域的核心竞争力，巩固其在中国乃至全球口腔医疗市场的引领地位。依托贝施美覆盖全国的临床服务网络、成熟的“BSM诊疗赋能方案”及多维度陪伴式支持体系，历德医疗的前沿种植技术与产品将快速落地中国市场，为口腔医疗机构提供更具竞争力的诊疗选择，同时让中国消费者无需远赴海外，即可享受到与国际同步的高品质种植服务。

作为国家高新技术企业，贝施美始终以推动行业进步为己任，持续为义齿加工企业与口腔临床机构赋能。此次与历德医疗的强强联合，将实现“全球资源+中国智造+本土服务”的深度融合，不仅为企业发展注入新动力，更为中国口腔医疗行业高质量发展树立了新典范。展望未来，双方将以此次合作为起点，持续深化合作维度，拓展合作领域，在全球口腔医疗舞台上书写更多跨界合作的精彩篇章，让优质口腔医疗资源惠及更多患者，共同推动人类口腔健康事业的进步。

英文版

Title: Besmile Partners with Italy’s Leader Medica to Usher in a New Era for China’s Dental Implant Industry

Chengdu, China, Jan. 23, 2026 – Chengdu Besmile Medical Technology Co., Ltd. ("Besmile") officially signed a strategic cooperation agreement with global leading dental implant firm Leader Medica ("LM") in Chengdu. A milestone for China’s dental industry’s integration with international advanced technologies, the partnership sees Besmile become LM’s exclusive general distributor in China. The two will integrate core resources to bring cutting-edge implant technologies and product solutions to the Chinese market, upgrade consumer experiences, and drive the industry toward standardization, internationalization and high-end development.

The cooperation followed over six months of in-depth due diligence and negotiations, reflecting both parties’ long-term vision. LM’s team visited Besmile’s Digital Intelligent Manufacturing Base in Chengdu Tianfu International Bio-Town multiple times, assessing its scale, R&D strength, intelligent manufacturing, market operations and global supply chain. Besmile’s modern facilities, full-industry-chain R&D system, global service network and qualification as an authorized manufacturer for U.S.-based BioRes won LM’s full trust, laying a solid foundation for collaboration.

The signing ceremony kicked off at 16:00 the same day, with LM representatives Andrea Minozzi and Congzhong Han, and Besmile Founder Mr. Yan Xinzhang, jointly signing the agreement. Hailed by the industry as a perfect integration of "global technology and Chinese intelligent manufacturing", the alliance will inject strong momentum into the dental sector.

Founded in 1994, LM has nearly 30 years of experience in dental implants, focusing on R&D, production and innovation. It boasts 12 full-industry-chain product lines, covering raw material processing to final packaging, and is globally recognized for its quality and digital innovation. "Since our establishment, quality and academic collaboration have been our core," said LM’s Andrea Minozzi. "Our partnership with Besmile stems from shared values in quality, R&D and digital layout. Going forward, LM’s implants will enter China via Besmile, while Besmile’s technologies will land in Europe through LM, achieving two-way empowerment and long-term win-win results."

Mr. Yan Xinzhang noted, "Dental implant technology originated in Europe with a solid academic and industrial foundation. We chose LM for its history, R&D strength and strict product standards. Besmile is committed to advancing China’s dental implant industry, and introducing LM’s premium Italian implants is part of this mission. We look forward to making LM’s products accessible to more Chinese patients, offering international-standard solutions."

A benchmark in China’s digital dental industry, Besmile was founded in 2013 with independent innovation at its core. It has built a full-industry-chain layout covering all-ceramic materials, implants and digital dental equipment, providing one-stop solutions globally. Holding certifications including China NMPA, EU CE and US FDA, and over 100 patents worldwide, Besmile operates in more than 100 countries, showcasing the strength of Chinese intelligent manufacturing in global healthcare.

This partnership is another key breakthrough in Besmile’s global layout, following its in-depth cooperation with BioRes. It will enrich Besmile’s product portfolio, strengthen its competitiveness and consolidate its leading position in China and globally. Leveraging Besmile’s nationwide clinical network, mature "BSM Diagnosis and Treatment Empowerment Program" and multi-dimensional support system, LM’s technologies and products will quickly enter the Chinese market, offering more competitive options for dental institutions and convenient, high-quality services for consumers.

As a national high-tech enterprise, Besmile is dedicated to promoting industrial progress. This alliance with LM will integrate "global resources + Chinese intelligent manufacturing + local services", setting a new model for China’s dental industry’s high-quality development. Looking ahead, the two parties will deepen cooperation, expand areas of collaboration, and bring high-quality dental care to more patients, jointly advancing global oral health.

郑重声明：此文内容为本网站转载企业宣传资讯，目的在于传播更多信息，与本站立场无关。仅供读者参考，并请自行核实相关内容。